A thermoplastic microfluidic microphysiological system to recapitulate hepatic function and multicellular interactions.


Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
12 2019
Historique:
received: 27 12 2018
revised: 29 03 2019
accepted: 04 04 2019
pubmed: 10 4 2019
medline: 17 9 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

Hepatic in vitro platforms ranging from multi-well cultures to bioreactors and microscale systems have been developed as tools to recapitulate cellular function and responses to aid in drug screening and disease model development. Recent developments in microfabrication techniques and cellular materials enabled fabrication of next-generation, advanced microphysiological systems (MPSs) that aim to capture the cellular complexity and dynamic nature of the organ presenting highly controlled extracellular cues to cells in a physiologically relevant context. Historically, MPSs have heavily relied on elastomeric materials in their manufacture, with unfavorable material characteristics (such as lack of structural rigidity) limiting their use in high-throughput systems. Herein, we aim to create a microfluidic bilayer model (microfluidic MPS) using thermoplastic materials to allow hepatic cell stabilization and culture, retaining hepatic functional phenotype and capturing cellular interactions. The microfluidic MPS consists of two overlapping microfluidic channels separated by a porous tissue-culture membrane that acts as a surface for cellular attachment and nutrient exchange; and an oxygen permeable material to stabilize and sustain primary human hepatocyte (PHH) culture. Within the microfluidic MPS, PHHs are cultured in the top channel in a collagen sandwich gel format with media exchange accomplished through the bottom channel. We demonstrate PHH culture for 7 days, exhibiting measures of hepatocyte stabilization, secretory and metabolic functions. In addition, the microfluidic MPS dimensions provide a reduced media-to-cell ratio in comparison with multi-well tissue culture systems, minimizing dilution and enabling capture of cellular interactions and responses in a hepatocyte-Kupffer coculture model under an inflammatory stimulus. Utilization of thermoplastic materials in the model and ability to incorporate multiple hepatic cells within the system is our initial step towards the development of a thermoplastic-based high-throughput microfluidic MPS platform for hepatic culture. We envision the platform to find utility in development and interrogation of disease models of the liver, multi-cellular interactions and therapeutic responses.

Identifiants

pubmed: 30963546
doi: 10.1002/bit.26986
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3409-3420

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Shyam Sundhar Bale (SS)

Draper, Cambridge, Massachusetts.

Andrea Manoppo (A)

Draper, Cambridge, Massachusetts.

Rebecca Thompson (R)

Draper, Cambridge, Massachusetts.

Alex Markoski (A)

Draper, Cambridge, Massachusetts.
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts.

Jonathan Coppeta (J)

Draper, Cambridge, Massachusetts.

Brian Cain (B)

Draper, Cambridge, Massachusetts.

Nerses Haroutunian (N)

Draper, Cambridge, Massachusetts.

Veronica Newlin (V)

Draper, Cambridge, Massachusetts.

Abbie Spencer (A)

Draper, Cambridge, Massachusetts.

Hesham Azizgolshani (H)

Draper, Cambridge, Massachusetts.

Mingjian Lu (M)

Pfizer Global Research and Development, Cambridge, Massachusetts.

James Gosset (J)

Pfizer Global Research and Development, Cambridge, Massachusetts.

Philip Keegan (P)

Draper, Cambridge, Massachusetts.

Joseph L Charest (JL)

Draper, Cambridge, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH